Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2013-07-09 16:18:52 UTC
Update Date2021-09-14 15:45:37 UTC
HMDB IDHMDB0061106
Secondary Accession Numbers
  • HMDB61106
Metabolite Identification
Common Name6beta-hydroxybudesonide
Description6β-hydroxybudesonide is a metabolite of budesonide. Budesonide is a glucocorticoid steroid for the treatment of asthma and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. In addition, it is used for Crohn's disease. (Wikipedia)
Structure
Data?1563866146
Synonyms
ValueSource
6b-HydroxybudesonideGenerator
6Β-hydroxybudesonideGenerator
Chemical FormulaC25H34O7
Average Molecular Weight446.5333
Monoisotopic Molecular Weight446.230453442
IUPAC Name(8S,9S,11S,13R,19R)-11,19-dihydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-14,17-dien-16-one
Traditional Name(8S,9S,11S,13R,19R)-11,19-dihydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-14,17-dien-16-one
CAS Registry NumberNot Available
SMILES
CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
InChI Identifier
InChI=1S/C25H34O7/c1-4-5-21-31-20-10-15-14-9-17(28)16-8-13(27)6-7-23(16,2)22(14)18(29)11-24(15,3)25(20,32-21)19(30)12-26/h6-8,14-15,17-18,20-22,26,28-29H,4-5,9-12H2,1-3H3/t14?,15?,17-,18+,20?,21?,22?,23+,24+,25-/m1/s1
InChI KeyJBVVDXJXIDYDMF-QNOBRMIYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassHydroxysteroids
Direct Parent21-hydroxysteroids
Alternative Parents
Substituents
  • Progestogin-skeleton
  • 21-hydroxysteroid
  • Pregnane-skeleton
  • 20-oxosteroid
  • 3-oxo-delta-1,4-steroid
  • 3-oxosteroid
  • 11-hydroxysteroid
  • 11-beta-hydroxysteroid
  • 6-hydroxysteroid
  • Oxosteroid
  • Delta-1,4-steroid
  • Meta-dioxolane
  • Cyclic alcohol
  • Alpha-hydroxy ketone
  • Cyclic ketone
  • Secondary alcohol
  • Ketone
  • Organoheterocyclic compound
  • Acetal
  • Oxacycle
  • Organic oxygen compound
  • Carbonyl group
  • Organooxygen compound
  • Alcohol
  • Primary alcohol
  • Hydrocarbon derivative
  • Organic oxide
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.33 g/LALOGPS
logP1.4ALOGPS
logP1.5ChemAxon
logS-3.1ALOGPS
pKa (Strongest Acidic)13.68ChemAxon
pKa (Strongest Basic)-2.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area113.29 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity117.63 m³·mol⁻¹ChemAxon
Polarizability46.96 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+200.07831661259
DarkChem[M-H]-200.08131661259
DeepCCS[M+H]+213.42330932474
DeepCCS[M-H]-211.330932474
DeepCCS[M-2H]-244.5430932474
DeepCCS[M+Na]+219.69630932474
AllCCS[M+H]+207.832859911
AllCCS[M+H-H2O]+205.732859911
AllCCS[M+NH4]+209.632859911
AllCCS[M+Na]+210.132859911
AllCCS[M-H]-206.432859911
AllCCS[M+Na-2H]-207.432859911
AllCCS[M+HCOO]-208.732859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.5.15 minutes32390414
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.5.13 minutes32390414
Predicted by Siyang on May 30, 202213.3857 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.06 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2840.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid195.0 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid188.1 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid172.2 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid140.2 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid580.4 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid552.2 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)109.1 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1088.1 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid486.7 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1661.4 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid348.8 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid423.3 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate272.8 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA200.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water10.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
6beta-hydroxybudesonideCCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO3468.6Standard polar33892256
6beta-hydroxybudesonideCCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO3120.8Standard non polar33892256
6beta-hydroxybudesonideCCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO3725.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
6beta-hydroxybudesonide,1TMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O13584.2Semi standard non polar33892256
6beta-hydroxybudesonide,1TMS,isomer #2CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O13557.6Semi standard non polar33892256
6beta-hydroxybudesonide,1TMS,isomer #3CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O13652.5Semi standard non polar33892256
6beta-hydroxybudesonide,1TMS,isomer #4CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O13620.7Semi standard non polar33892256
6beta-hydroxybudesonide,2TMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O13454.6Semi standard non polar33892256
6beta-hydroxybudesonide,2TMS,isomer #2CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O13551.4Semi standard non polar33892256
6beta-hydroxybudesonide,2TMS,isomer #3CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O13509.5Semi standard non polar33892256
6beta-hydroxybudesonide,2TMS,isomer #4CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O13513.4Semi standard non polar33892256
6beta-hydroxybudesonide,2TMS,isomer #5CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O13474.2Semi standard non polar33892256
6beta-hydroxybudesonide,2TMS,isomer #6CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O13588.4Semi standard non polar33892256
6beta-hydroxybudesonide,3TMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O13442.3Semi standard non polar33892256
6beta-hydroxybudesonide,3TMS,isomer #2CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O13406.0Semi standard non polar33892256
6beta-hydroxybudesonide,3TMS,isomer #3CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O13470.5Semi standard non polar33892256
6beta-hydroxybudesonide,3TMS,isomer #4CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O13428.2Semi standard non polar33892256
6beta-hydroxybudesonide,4TMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O13372.6Semi standard non polar33892256
6beta-hydroxybudesonide,4TMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O13553.7Standard non polar33892256
6beta-hydroxybudesonide,4TMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O14107.2Standard polar33892256
6beta-hydroxybudesonide,1TBDMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O13808.4Semi standard non polar33892256
6beta-hydroxybudesonide,1TBDMS,isomer #2CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O13791.7Semi standard non polar33892256
6beta-hydroxybudesonide,1TBDMS,isomer #3CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O13897.3Semi standard non polar33892256
6beta-hydroxybudesonide,1TBDMS,isomer #4CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O13843.9Semi standard non polar33892256
6beta-hydroxybudesonide,2TBDMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O13922.8Semi standard non polar33892256
6beta-hydroxybudesonide,2TBDMS,isomer #2CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O14024.0Semi standard non polar33892256
6beta-hydroxybudesonide,2TBDMS,isomer #3CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O13949.3Semi standard non polar33892256
6beta-hydroxybudesonide,2TBDMS,isomer #4CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O13991.5Semi standard non polar33892256
6beta-hydroxybudesonide,2TBDMS,isomer #5CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O13923.8Semi standard non polar33892256
6beta-hydroxybudesonide,2TBDMS,isomer #6CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O14051.8Semi standard non polar33892256
6beta-hydroxybudesonide,3TBDMS,isomer #1CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O14118.5Semi standard non polar33892256
6beta-hydroxybudesonide,3TBDMS,isomer #2CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O14063.5Semi standard non polar33892256
6beta-hydroxybudesonide,3TBDMS,isomer #3CCCC1OC2CC3C4C[C@@H](O[Si](C)(C)C(C)(C)C)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O14148.0Semi standard non polar33892256
6beta-hydroxybudesonide,3TBDMS,isomer #4CCCC1OC2CC3C4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)C4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O14114.3Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 6beta-hydroxybudesonide GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-1940400000-e034a283d142e57d7bbf2017-09-20Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 6beta-hydroxybudesonide GC-MS (3 TMS) - 70eV, Positivesplash10-000t-2420369000-d70981cfbf30d7e5c1c82017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 6beta-hydroxybudesonide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 6beta-hydroxybudesonide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 10V, Positive-QTOFsplash10-01t9-0001900000-fc18dfdc14a7517d4aa22017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 20V, Positive-QTOFsplash10-08i0-2034900000-0cf7b143aafb7b1b776f2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 40V, Positive-QTOFsplash10-0a4l-9147100000-bd399aa4076ea88d9c9d2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 10V, Negative-QTOFsplash10-0002-1004900000-e8fbbf52952c83c734592017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 20V, Negative-QTOFsplash10-056s-3009700000-94c3200a5ea123edc6972017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 40V, Negative-QTOFsplash10-0avu-5019000000-fa40d4cc601360d6a1b62017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 10V, Positive-QTOFsplash10-0002-0001900000-23b08540812aeb0a39c32021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 20V, Positive-QTOFsplash10-0a4i-0119300000-a4a54e9634f6e125aa5b2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 40V, Positive-QTOFsplash10-004i-1980100000-bc8cd310b2cb3113e9872021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 10V, Negative-QTOFsplash10-0002-0000900000-6b791fbfcbe73e12d3e82021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 20V, Negative-QTOFsplash10-0002-1004900000-3a29af8bd45f8a0ad6962021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 6beta-hydroxybudesonide 40V, Negative-QTOFsplash10-0a4i-9361100000-fc3ebbfcfe280af41ae82021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound131770031
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
  2. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
  3. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
  4. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
  5. Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.